OBI-999

· OBI Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OBI-999, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Study of OBI-999 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]